Ruby Cai

543 total citations
9 papers, 349 citations indexed

About

Ruby Cai is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ruby Cai has authored 9 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Ruby Cai's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (3 papers) and Hepatitis C virus research (3 papers). Ruby Cai is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (3 papers) and Hepatitis C virus research (3 papers). Ruby Cai collaborates with scholars based in United States and Belgium. Ruby Cai's co-authors include Janet L. Douglas, Edmund Ho, Kuei‐Ying Lin, Tomáš Cihlář, S. Swaminathan, Choung U. Kim, Haolun Jin, Salman Jabri, Manuel Tsiang and Xiaowu Chen and has published in prestigious journals such as Journal of Virology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ruby Cai

9 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruby Cai United States	9	186	162	85	82	62	9	349
Jérôme Deval United States	8	118 0.6×	237 1.5×	146 1.7×	114 1.4×	35 0.6×	13	402
Nathalie Dansereau Canada	9	203 1.1×	125 0.8×	46 0.5×	15 0.2×	36 0.6×	11	320
Brian D. Herman United States	7	78 0.4×	346 2.1×	59 0.7×	39 0.5×	33 0.5×	10	439
Karl Frank United States	11	161 0.9×	139 0.9×	112 1.3×	89 1.1×	39 0.6×	17	362
Choi-Lai Tiong-Yip United States	7	166 0.9×	63 0.4×	105 1.2×	19 0.2×	12 0.2×	7	264
April Kinkade United States	7	194 1.0×	114 0.7×	52 0.6×	48 0.6×	39 0.6×	9	353
Nadejda Valiaeva United States	10	141 0.8×	160 1.0×	78 0.9×	33 0.4×	34 0.5×	20	293
Mary C. Long United States	14	204 1.1×	195 1.2×	165 1.9×	47 0.6×	26 0.4×	19	438
Jan Olof Noren Sweden	6	231 1.2×	164 1.0×	167 2.0×	34 0.4×	90 1.5×	8	474
Alfred M. Prince United States	9	290 1.6×	52 0.3×	52 0.6×	30 0.4×	16 0.3×	9	434

Countries citing papers authored by Ruby Cai

Since Specialization

Citations

This map shows the geographic impact of Ruby Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Cai more than expected).

Fields of papers citing papers by Ruby Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Cai. The network helps show where Ruby Cai may publish in the future.

Co-authorship network of co-authors of Ruby Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Cai. A scholar is included among the top collaborators of Ruby Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Cai. Ruby Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Balakrishnan, Mini, et al.. (2021). GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture. Antimicrobial Agents and Chemotherapy. 65(5). 24 indexed citations

2.

Cai, Ruby, William E. Delaney, Zhimin Du, et al.. (2014). Highly Potent HCV NS4B Inhibitors with Activity against Multiple Genotypes. Journal of Medicinal Chemistry. 57(5). 2161–2166. 21 indexed citations

3.

Appleby, T.C., Thomas Butler, Ruby Cai, et al.. (2012). Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 22(7). 2629–2634. 26 indexed citations

4.

Casarez, Anthony, Ruby Cai, Michael O. Clarke, et al.. (2011). Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity. Bioorganic & Medicinal Chemistry Letters. 22(3). 1394–1396. 28 indexed citations

5.

Jin, Haolun, Matthew Wright, Richard Pastor, et al.. (2008). Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs. Bioorganic & Medicinal Chemistry Letters. 18(4). 1388–1391. 17 indexed citations

6.

Fardis, Maria, Haolun Jin, Salman Jabri, et al.. (2006). Effect of substitution on novel tricyclic HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 4031–4035. 29 indexed citations

7.

Jin, Haolun, Ruby Cai, Salman Jabri, et al.. (2006). Design, synthesis, and SAR studies of novel and highly active tri-cyclic HIV integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 3989–3992. 33 indexed citations

8.

Douglas, Janet L., Edmund Ho, Kuei‐Ying Lin, et al.. (2005). Small Molecules VP-14637 and JNJ-2408068 Inhibit Respiratory Syncytial Virus Fusion by Similar Mechanisms. Antimicrobial Agents and Chemotherapy. 49(6). 2460–2466. 76 indexed citations

9.

Douglas, Janet L., Edmund Ho, Kuei‐Ying Lin, et al.. (2003). Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein. Journal of Virology. 77(9). 5054–5064. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact